We give you access to small quantities of licensed molecules from EMA- and FDA-approved medicines for your R&D.
As a licensed pharmaceutical wholesaler, we buy FDA/EMA-approved medicines from manufacturers and authorized wholesalers in the United States and Europe.
The medicines are divided into small aliquots under sterile, aseptic conditions in a laminar flow environment. The size of the aliquots can vary from 0.02 mg to 500 mg. Our trained laboratory team ensures reproducibility, precise handling, and full traceability.
Aliquots are stored frozen at -70°C in monitored freezers, keeping the molecules viable years beyond their therapeutic expiration date. They’re ready for analytical and in vitro research when you need them.
When developing a New Biological Entity (NBE) or biosimilar, accuracy depends on comparing your investigational molecule to the actual licensed product. With Evidentic, you have access to the exact reference medicine – same molecule, same formulation.
Avoid paying for full vials when you only need milligrams. Our aliquots preserve the original concentration and buffer, helping you save on costs without compromising quality.
Compare your investigational molecule to different batches of the same reference medicine. Getting access to multiple batches is a challenge through standard channels, but routine at Evidentic. This enables deeper comparability studies and more robust early results.
Once qualified, your order ships within days – keeping your project timelines moving forward.
Discover how Evidentic helps you source licensed reference products to support characterization, stability, and functional studies – without sourcing delays.
See how Evidentic helps you gain access to clinical-grade molecules in original formulations so you can deliver precise, reliable results for your customers.
Explore how Evidentic helps you expand your critical quality attribute (CQA) dataset with multiple batches of the reference product, save on research costs, and accelerate your development timeline.
Learn how Evidentic helps you secure small quantities of therapeutic-grade molecules to advance your studies and publish with real-world relevance – all while staying within budget.
Browse our shop and choose the licensed molecules you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!
Receive a confidential, non-binding quote for the molecule(s) you choose.
Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.
We are thankful and more than happy to work with the Evidentic. Not only are the drug aliquots in the best quality and satisfy our requests to the full extent, but also can we absolutely rely on the whole Evidentic team.
We develop innovative and biosimilar mAbs for a global market. Evidenticメs aRMPs are a great source of cost-efficient reference products for our research and development program.
Evidentic drug aliquots have significantly reduced our development cycle time and strengthened our ability to do detailed [protein] characterization.
Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!
After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries.
Evidentic’s reference materials enable reliable evaluation of Critical Quality Attributes across different batches, helping us assess and understand product variability with confidence.
At Quality Assistance, we use Evidentic’s commercially sourced antibodies and ADCs to develop generic analytical methods that can later be offered as services to our clients, and to showcase our analytical expertise. The availability of these clinical-grade molecules in ready-to-use aliquot formats – including access to different batches with varying expiry dates – is particularly valuable for method development, optimization, and building relevant case studies.
Evidentic’s drug aliquots helped us to ascertain the efficacy of our novel molecule [in comparison to commercial therapeutic antibody] which supported our fundraising efforts.
From ADCs to monoclonal antibodies – find insights that help you drive your early-stage research forward.